 ROCKVILLE, Md. and SHANGHAI, Jan. 28, 2021 PRNewswire -- Cellular Biomedicine Group, Inc. Nasdaq: CBMG Company, CBMG, we or our, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases,... 